Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Downregulation of olfactomedin-4 (OLFM4) is associated with tumor progression, lymph node invasion and metastases. However, whether or not downregulation of OLFM4 is associated with epigenetic silencing remains unknown. In this study, we investigate the role of OLFM4 in gastric cancer cell invasion. We confirm the previous result that OLFM4 expression is increased in gastric cancer tissues and decreases with an increasing number of metastatic lymph nodes, which are associated with OLFM4 promoter hypermethylation. Overexpression of OLFM4 in gastric cancer cells had an inhibitory effect on cell invasion. Furthermore, we found that focal adhesion kinase (FAK) was negatively correlated with OLFM4 in regards to lymph node metastasis in gastric cancer tissues. Also, inhibition of FAK induced by OLFM4 knockdown resulted in a decrease in cell invasion. Thus, our study demonstrates that epigenetic silencing of OLFM4 enhances gastric cancer cell invasion via activation of FAK signaling.
Abstract
Downregulation of olfactomedin-4 (OLFM4) is associated with tumor progression, lymph node invasion and metastases. However, whether or not downregulation of OLFM4 is associated with epigenetic silencing remains unknown. In this study, we investigate the role of OLFM4 in gastric cancer cell invasion. We confirm the previous result that OLFM4 expression is increased in gastric cancer tissues and decreases with an increasing number of metastatic lymph nodes, which are associated with OLFM4 promoter hypermethylation. Overexpression of OLFM4 in gastric cancer cells had an inhibitory effect on cell invasion. Furthermore, we found that focal adhesion kinase (FAK) was negatively correlated with OLFM4 in regards to lymph node metastasis in gastric cancer tissues. Also, inhibition of FAK induced by OLFM4 knockdown resulted in a decrease in cell invasion. Thus, our study demonstrates that epigenetic silencing of OLFM4 enhances gastric cancer cell invasion via activation of FAK signaling.
참고문헌 (25)
- Clemmensen SN, "Olfactomedin 4 defines a subset of human neutrophils", J Leukoc Biol, 91, pp.495~500 (2012)
- Chin KL, "The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor", Br J Haematol, 143, pp.421~432 (2008)
- Sun F, "Transcriptomic signatures of attachment, NF-kappaB suppression and IFN stimulation in the catfish gill following columnaris bacterial infection", Dev Comp Immunol, 38, pp.169~180 (2012)
- Grover PK, "Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis", Cancer Metastasis Rev, 29, pp.761~775 (2010)
- Besson D, "A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker", Mol Cell Proteomics, 10, pp.111~9712 (2011)
- Yu L, "Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers", Neoplasma, 58, pp.9~13 (2011)
- Sampieri CL, "Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers", J Cancer Res Ther, 9, pp.356~363 (2013)
- Jang BG, "Olfactomedin-related proteins 4(OLFM4)expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer", Virchows Arch, 467, pp.285~294 (2015)
- Luo Z, "OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer", J Cancer Res Clin Oncol, 137, pp.1713~1720 (2011)
- Yamanoi K, "Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome", Carcinogenesis, 36, pp.509~520 (2015)
- Carneiro P, "Therapeutic targets associated to E-cadherin dysfunction in gastric cancer", Expert Opin Ther Targets, 17, pp.1187~1201 (2013)
- Koshida S, "Specific overexpression of OLFM4(GW112", HGC-1)mRNA in colon, breast and lung cancer tissues detected using quantitative analysis, 2007, pp.98, 315~320
- Liu W, "Expression of hGC-1 is correlated with differentiation of gastric carcinoma", Histopathology, 51, pp.157~165 (2007)
- Oue N, "Serum olfactomedin 4(GW112, hGC-1)in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients", Int J Cancer, 125, pp.2383~2392 (2009)
- Suh YS, "The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer", Ann Surg Oncol, 19, pp.1240~1249 (2012)
- He D, "Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas", Med Oncol, 32, pp.92~ (2015)
- Zouridis H, "Methylation subtypes and large-scale epigenetic alterations in gastric cancer", Sci Transl Med, 4, pp.140~156 (2012)
- Dauksa A, "DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer", Anticancer Res, 34, pp.5381~5388 (2014)
- Zhao C, "Promoter methylation of tumor-related genes in gastric carcinogenesis", Histol Histopathol, 27, pp.1271~1282 (2012)
- Du T, "Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK", Paxillin pathway, 2014, pp.13, 100~
- Roberts WG, "Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562, 271", Cancer Res, 68, pp.1935~1944 (2008)
- Mon NN, "FAK signaling in neoplastic disorders: a linkage between inflammation and cancer", Ann N Y Acad Sci, 1086, pp.199~212 (2006)
- Zhang J, "Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development", Gene, 283, pp.83~93 (2002)
- 박기선, "Olfactomedin 4 Suppresses Tumor Growth and Metastasis of Mouse Melanoma Cells through Downregulation of Integrin and MMP Genes", Molecules and Cells, 34(6), pp.555~561 (2012), 한국분자세포생물학회
- Liu RH, "Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells", J Biomed Sci, 19, pp.38~ (2012)